Analyzing Genetic Variants in Parkinson's Disease
Author Information
Author(s): Hong Samantha, Koretsky Mathew J., Lichtenberg Jens, Leonard Hampton, Pitz Vanessa
Primary Institution: Global Parkinson’s Genetics Program (GP2)
Hypothesis
The study aims to evaluate the genotyping success of the NeuroBooster array and determine the frequencies of pathogenic variants across different ancestries.
Conclusion
The study confirms that established Parkinson's disease genes are likely pathogenic and emphasizes the need for diverse ancestry research.
Supporting Evidence
- Genes predicted to cause Parkinson's disease have more pathogenic variants across different ancestries.
- Twenty-five of the 34 pathogenic variants were successfully genotyped using the NeuroBooster array.
Takeaway
Scientists looked at genes that might cause Parkinson's disease in many different people and found that some genes are important for understanding the disease.
Methodology
The study analyzed 34 pathogenic variants in 28,710 PD cases, 9,614 other neurodegenerative disorder cases, and 15,821 controls across 11 ancestries using the NeuroBooster array.
Participant Demographics
Participants included individuals from 11 different ancestries.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website